Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Revenue: 2009-2024

Historic Revenue for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to $1.3 billion.

  • Cross Country Healthcare's Revenue fell 2064.84% to $250.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 2214.12%. This contributed to the annual value of $1.3 billion for FY2024, which is 3345.62% down from last year.
  • According to the latest figures from FY2024, Cross Country Healthcare's Revenue is $1.3 billion, which was down 3345.62% from $2.0 billion recorded in FY2023.
  • In the past 5 years, Cross Country Healthcare's Revenue ranged from a high of $2.8 billion in FY2022 and a low of $836.4 million during FY2020
  • Over the past 5 years, Cross Country Healthcare's median Revenue value was $1.7 billion (recorded in 2021), while the average stood at $1.7 billion.
  • In the last 5 years, Cross Country Healthcare's Revenue surged by 10045.65% in 2021 and then crashed by 3345.62% in 2024.
  • Annual analysis of 5 years shows Cross Country Healthcare's Revenue stood at $836.4 million in 2020, then soared by 100.46% to $1.7 billion in 2021, then skyrocketed by 67.2% to $2.8 billion in 2022, then decreased by 27.95% to $2.0 billion in 2023, then plummeted by 33.46% to $1.3 billion in 2024.
  • Its last three reported values are $1.3 billion in FY2024, $2.0 billion for FY2023, and $2.8 billion during FY2022.